- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05401253
The Association of Different Levels of Physical Activity on Postoperative Pulmonary Complications in Patients Undergoing Thoracoscopic Lung Resection Surgery
March 10, 2024 updated by: Changping Gu, Qianfoshan Hospital
The Association of Different Levels of Physical Activity on Postoperative Pulmonary Complications in Patients Undergoing Thoracoscopic Lung Resection Surgery: A Prospective Cohort Study
This study aimed to predict different physical activity (PA) levels in patients undergoing thoracoscopic lung resection surgery (LRS) using the International Physical Activity Questionnaire (IPAQ) and investigate the association between the PA levels and the incidence of postoperative pulmonary complications (PPCs).
The patients were classified into the high-level and low-level PA groups based on the IPAQ scores.
The incidence of PPCs within postoperative 5 days, number of PPCs, the incidence of postoperative adverse events (PAEs) within postoperative 5 days, extubation time, length of hospital stay (LOS), unplanned admission to the intensive care unit (ICU), and the mortality 1-month postoperatively were recorded.
Arterial blood samples were collected before induction of anesthesia and 1 hour postoperatively, and the supernatants were centrifuged for cytokine analysis.
Binomial logistic analysis was performed to determine the relationship between predefined variables and PPCs.
Receiver operating characteristic (ROC) curve analysis was performed to identify independent risk factors, and the area under the curve (AUC) was calculated.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
245
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250014
- China, Shandong Qianfoshan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients aged 18~80 years undergoing elective thoracoscopic lung resection surgery under general anesthesia
Description
Inclusion Criteria:
- Patients older than 18 years and younger than 80 years;
- Patients scheduled to accept elective thoracic surgery under general anesthesia;
- Patients of American Society of Anesthesiologists (ASA) Ⅱ~Ⅲ level grade;
- Patients signed the informed consent form for the clinical study.
Exclusion Criteria:
- Patients with moderate or severe chronic obstructive pulmonary disease (GOLD Grade III or IV level grade);
- Patients with severe or uncontrolled bronchial asthma;
- Patients with severe neuromuscular disease or thoracic malformation;
- Patients with severe heart disease (New York Heart Association Class III or IV level grade or acute coronary syndrome or persistent ventricular arrhythmia);
- Patients with cognitive dysfunction;
- Patients who have participated in other clinical trials within the previous 30 days;
- Patients with coagulation dysfunction;
- Patients who received radiotherapy or chemotherapy within 2 months before surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Adequate physical activity group
At least 600 met-minutes /week for five or more days of walking, moderate and strenuous physical activity per week.
|
|
Insufficient physical activity group
Less than 600 met-minutes /week for five or more days of walking, moderate and strenuous physical activity per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of pulmonary complications
Time Frame: Within five days after surgery
|
|
Within five days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Extubation time
Time Frame: The time from the end of surgery to the removal of the endotracheal intubation.
|
The time from the end of surgery to the removal of the endotracheal intubation.
|
|
|
Postoperative length of stay
Time Frame: During the study procedure
|
During the study procedure
|
|
|
The number of postoperative pulmonary complications
Time Frame: Within five days after the surgery
|
Within five days after the surgery
|
|
|
Mortality 1 month after surgery
Time Frame: Within 1 month of the end of surgery
|
Within 1 month of the end of surgery
|
|
|
The arterial levels of inflammatory markers
Time Frame: before induction of anesthesia(T0),1.5 hours after the beginning of surgery(T2),3 hours after the beginning of surgery(T3)and 1 hour after the end of surgery(T4).
|
interleukin-6(IL-6), interleukin-8(IL-8), tumor necrosis factor-α(TNF-α)
|
before induction of anesthesia(T0),1.5 hours after the beginning of surgery(T2),3 hours after the beginning of surgery(T3)and 1 hour after the end of surgery(T4).
|
|
Incidence of postoperative adverse events
Time Frame: Within five days after operation
|
|
Within five days after operation
|
|
Unplanned admission to the ICU
Time Frame: Within five days after operation
|
Within five days after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Changping Gu, doctor, Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Actual)
November 30, 2023
Study Completion (Actual)
November 30, 2023
Study Registration Dates
First Submitted
April 25, 2022
First Submitted That Met QC Criteria
May 27, 2022
First Posted (Actual)
June 2, 2022
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 10, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- YXLL-KY-2022(014)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Pulmonary Complications
-
Aga Khan UniversityCompletedPostoperative Complications | Pulmonary Complication | Postoperative Pulmonary ComplicationsPakistan
-
Istinye UniversityNot yet recruitingPostoperative Pulmonary ComplicationsTurkey (Türkiye)
-
Min SuNot yet recruitingPostoperative Pulmonary ComplicationsChina
-
Britta TrautweinRecruitingPostoperative Pulmonary ComplicationsGermany
-
Beijing Tongren HospitalBeijing Chest HospitalCompletedUsing Thoracic Paravertebral Block for Perioperative Lung Preservation During VATS Pulmonary SurgeryPostoperative Pulmonary ComplicationsChina
-
Wuhan Union Hospital, ChinaRecruitingPostoperative Pulmonary ComplicationsChina
-
Xuzhou Medical UniversityUnknownPostoperative Pulmonary ComplicationsChina
-
Wuhan Union Hospital, ChinaQinghai People's Hospital; Wuhan Central Hospital; Shanxi Cardiovascular Hospital and other collaboratorsNot yet recruitingPostoperative Pulmonary Complications
-
Wuhan Union Hospital, ChinaNot yet recruitingPostoperative Pulmonary Complications
-
University Health Network, TorontoNot yet recruiting